Exercise of options and total voting rights
Abingdon Health plc has announced the exercise of share options, resulting in the application for 5,208 new ordinary shares to be admitted to trading on AIM on December 30, 2025. Following this issuance, the company's total issued ordinary shares will be 251,077,850, with no shares held in treasury. This figure will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Select text to share a quote on X · sign in to keep highlights & notes in your ABDX notes
York, U.K. 29 December 2025: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and distributor of high quality and effective rapid tests, announces that it has applied for 5,208 new ordinary shares of 0.025 pence each ("Ordinary Shares") in the Company to be admitted to trading on AIM on 30 December 2025 following an exercise of share options.
Following the issue of the 5,208 new Ordinary Shares the Company will have a total of 251,077,850 Ordinary Shares in issue. The Company does not hold any shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.